Chen S, Liu D, Chen H, Liao A, et al. The efficacy and safety of keverprazan, a novel potassium-competitive acid
blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind
multicentre study. Aliment Pharmacol Ther 2022;55:1524-1533.
PMID: 35505467